Original from: 360DX
The US Food and Drug Administration this week granted separate Emergency Use Authorizations for over-the-counter SARS-CoV-2 antigen self-tests developed by Osang Healthcare.
Osang's OHC COVID-19 Antigen Self Test is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in self-collected or adult-collected anterior nasal swabs.
About a year ago, South Korea-based Osang inked a US distribution deal for its GeneFinder COVID-19 Plus RealAmp Kit with Todos Medical.
Source: Osang Healthcare Get FDA Emergency Use Authorization for COVID-19 Antigen Test
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.
Go back
